India's Panacea Biotec to produce 100 mln Sputnik V doses annually -RDIF

Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.

RDIF did not say when production would begin.

 

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)